Investing
Novartis adj net income grows 6%, below market view
© Reuters. The company’s logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann
By Ludwig Burger
FRANKFURT (Reuters) -Novartis on Wednesday reported a gain of 6% in fourth-quarter adjusted net income, helped by cost cuts and strong growth of recently launched drugs.
Core net income for the quarter came in at $3.13 billion, the Swiss drugmaker said in a statement, missing an average analyst estimate of about $3.3 billion.
The company also extended its mid-term guidance, saying it expected sales to grow 5% per year until 2028, when adjusting for currency swings. It had previously projected that pace of growth through 2027.
It reiterated that the core operating income margin would expand to about 40% or more by 2027.
Read the full article here
-
Side Hustles6 days ago
3 Steps You Can’t Miss When Growing Your Business
-
Side Hustles7 days ago
How to Maximize Your Profits With This Annual 8-Step Checklist
-
Passive Income7 days ago
Why Email Marketing Is Still Your Business’s Most Powerful Tool
-
Side Hustles7 days ago
Want to Start a Business? Consider Buying One Instead — Here’s Why.
-
Make Money6 days ago
Here’s the Typical American’s Income at Every Age. How Do You Compare?
-
Investing6 days ago
Germany stocks lower at close of trade; DAX down 0.65% By Investing.com
-
Investing6 days ago
How I Transformed My Business by Letting Go of Low-Value Tasks
-
Investing7 days ago
Barbara Corcoran Says She Fired Her Mother: Business Lessons